Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences Ltd is a Canadian company, focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. It develops a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. Its lead product, ColonSentry is a blood test to determine the patient's current risk of having colorectal cancer.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

I wonder if Mykndrsn is involved?

Jeff Bezos, Bill Gates, and other billionaires are backing an exploration for rare minerals buried beneath Greenland's ice. more

We'll talk shop on Monday. Weekends are for sh!ts & giggles.

  rate and reply

Neovasc Announces Second Quarter Financial Results

Generated revenues of $818,000, a quarterly record and a year-over-year increase of 29% over the second quarter of 2021. And COSIRA II protocol supplement was approved by the FDA, more than doubling the total number of patients and adding specific patient groups eligible and allowed for treatment in the trial. more


Any guesses on what to expect? I just got back in and was just curious what you guys were thinking.  rate and reply
@ the Bell: TSX up at the end of the week on broad gains
The major deal between Canada’s two main telecom companies, Rogers and Shaw, made progress on Friday, helping the TSX close higher in a broad increase across sectors. Gains were capped on concerns... read article.

RE:RE:Investing chat rooms like this....

literally the post that will forever hold the worlds record for most pointless worthless post ever posted on this website congrats loser  rate and reply

RE:Investing chat rooms like this....

  rate and reply

Down 10% Before News

That means its good right! I want to be the first to say "way to go team investment crunchers" on this coming epic of all tuesdays.  rate and reply

RE:Tuesday it is.

when will someone say "having it tuesday is a good sign cause its not after close on a friday" like it matters All investors need is Michael Buffer to come out and say "Are you more

Tuesday it is.

TORONTO, ON / ACCESSWIRE / August 12, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its second more
The Market Herald’s Weekly Cannabis Report. August 12, 2022
Aleafia Health (TSX:AH) earns record quarter-over-quarter revenue in Q1 2023Source: Aleafia Health Inc.Aleafia Health (AH) reported its financial results for the three months ended June 30,... read article.

New Press Release - StageZero to Hold Q2 2022 Operational and Financial Results Conference Call on Tuesday August 16, 2022

TORONTO, ON / ACCESSWIRE / August 12, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its second quarter operational and financial results before the markets open on Tuesday, August 16, 2022. StageZero's Chairman and CEO, James article.

RE:Nail biter

Meh. I'm not the one sittig at the kiddie table crying for milk. BTW, your DMs are on auto-flush and I don't have a square to spare amigo. Try holding it in a little longer. Just over more

Nail biter

Stop talking to yourself. Maybe try calling Tripp ask him if he's done lying to us finally   rate and reply


  rate and reply

RE:RE:Investing chat rooms like this....

5 days a week from 9 to 5 here.  rate and reply

Next week

QuarterRelease  rate and reply
Buzz on the Bullboards: Defying market expectations
Most market reviews are throwing around the dreaded R-word, “recession” like it’s going out of style. Once again, news headlines indicate that the markets may be steering towards one. It turns out... read article.


You're safe where you are buddy. You'll be glad to know, my wife and I have chosen to start our Commie commune on the beautiful Manitoulin. Awesome fishing, walleye and trout. more

RE:RE:RE:RE:Share price

I think it's safe to say to many sales involve terms. Ichor, large employers etc. Individuals not so much.   rate and reply

RE:RE:RE:RE:Share price

It is starting to look like even through the financials we will still have no idea of how how many Aristotle tests were paid for and if the numbers are on a upward trend , after nearly a year and more

RE:RE:RE:Share price

Everything I've read is you have to pay up front to receive the tests, you have done the test, did they bill you or did you have to pay up front?  we haven't seen any Hospital more

RE:RE:Share price

Important to remember due to segment acconting rules accounts receivable aren't included in revenue. Everything is delayed until the bill is paid. Creates an obvious lag in reporting sales.   rate and reply

RE:Investing chat rooms like this....

Yuuuppp  rate and reply